ReviewFolia microbiologica2026
Structural, functional, and evolutionary perspectives of bacterial iron repertoire: bacterioferritin and bacterioferritin-associated ferredoxin as emerging targets against antibiotic resistance.
Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterioferritin (Bfr), traditionally recognized as a bacterial iron storage protein, functions synergistically with its partner, bacterioferritin-associated ferredoxin (Bfd), which mediates iron release. Recent research has highlighted these proteins for their remarkable structural characteristics and their indispensable role in maintaining cellular iron homeostasis. Their evolutionary conservation across diverse bacterial lineages indicates broader physiological functions, such as supporting cellular maintenance, enhancing virulence, and facilitating stress adaptation. Bfr forms a 24-meric macromolecular assembly that stores iron in its ferric state, thereby protecting the cell from iron-induced oxidative stress. In contrast, twelve Bfd molecules associated with Bfr facilitate iron mobilization by electron donation, reducing ferric to ferrous iron, thus enabling its release from the Bfr cage. This regulated system of iron sequestration and mobilisation is widespread among bacteria, but is notably absent in Lactobacilli. This review explores the structural dynamics and evolutionary conservation of Bfr and Bfd, emphasising their molecular interactions. Considering the escalating threat of antimicrobial resistance (AMR), disrupting this essential protein–protein interface presents a promising therapeutic strategy. By providing detailed insights into their structure, function, and evolutionary relevance, this review identifies the Bfr-Bfd complex as a potential target for developing novel antimicrobial interventions.
Indexed as
Identifiers
41774322What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.